American Journal of Epidemiology Advance Access originally published online on January 29, 2008
American Journal of Epidemiology 2008 167(7):775-785; doi:10.1093/aje/kwm375
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Time Lines of Infection and Disease in Human Influenza: A Review of Volunteer Challenge Studies
1 Université Pierre et Marie Curie-Paris6, UMR-S 707, Paris, France
2 INSERM, UMR-S 707, Paris, France
3 Assistance Publique Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France
4 Mathématiques et Informatique Appliqués Unit, Institut National de la Recherche Agronomique, Jouy-en-Josas, France
5 Department of Infectious Disease Epidemiology, Faculty of Medicine, Imperial College London, London, United Kingdom
6 Health Protection Agency, Centre for Emergency Preparedness and Response, Porton Down, Salisbury, Wiltshire, United Kingdom
Correspondence to Dr. F. Carrat, Epidémiologie, Systèmes d'Information, Modélisation, UMR-S 707, Faculté de médecine Saint-Antoine, 27, rue Chaligny, 75571, Paris Cedex 12, France (e-mail: carrat{at}u707.jussieu.fr).
Received for publication September 20, 2007. Accepted for publication November 30, 2007.
The dynamics of viral shedding and symptoms following influenza virus infection are key factors when considering epidemic control measures. The authors reviewed published studies describing the course of influenza virus infection in placebo-treated and untreated volunteers challenged with wild-type influenza virus. A total of 56 different studies with 1,280 healthy participants were considered. Viral shedding increased sharply between 0.5 and 1 day after challenge and consistently peaked on day 2. The duration of viral shedding averaged over 375 participants was 4.80 days (95% confidence interval: 4.31, 5.29). The frequency of symptomatic infection was 66.9% (95% confidence interval: 58.3, 74.5). Fever was observed in 37.0% of A/H1N1, 40.6% of A/H3N2 (p = 0.86), and 7.5% of B infections (p = 0.001). The total symptoms scores increased on day 1 and peaked on day 3. Systemic symptoms peaked on day 2. No such data exist for children or elderly subjects, but epidemiologic studies suggest that the natural history might differ. The present analysis confirms prior expert opinion on the duration of viral shedding or the frequency of asymptomatic influenza infection, extends prior knowledge on the dynamics of viral shedding and symptoms, and provides original results on the frequency of respiratory symptoms or fever.
influenza, human; signs and symptoms; virus shedding
Abbreviations: CI, confidence interval; GEE, generalized estimating equations; HAI, hemagglutination inhibition; SD, standard deviation
Editor's note: References 83–111 are cited in the Web-only Supplementary Material posted on the Journal's website (http://aje.oxfordjournals.org/).
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Srinivasan and T. M. Perl Respiratory Protection Against Influenza JAMA, November 4, 2009; 302(17): 1903 - 1904. [Full Text] [PDF]
|
|
|
|
|
|
G. Dominguez-Cherit, S. E. Lapinsky, A. E. Macias, R. Pinto, L. Espinosa-Perez, A. de la Torre, M. Poblano-Morales, J. A. Baltazar-Torres, E. Bautista, A. Martinez, et al. Critically Ill Patients With 2009 Influenza A(H1N1) in Mexico JAMA, November 4, 2009; 302(17): 1880 - 1887. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Cowling, K.-H. Chan, V. J. Fang, C. K.Y. Cheng, R. O.P. Fung, W. Wai, J. Sin, W. H. Seto, R. Yung, D. W.S. Chu, et al. Facemasks and Hand Hygiene to Prevent Influenza Transmission in Households: A Cluster Randomized Trial Ann Intern Med, October 6, 2009; 151(7): 437 - 446. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Santibanez, A. E. Fiore, T. L. Merlin, and S. Redd A Primer on Strategies for Prevention and Control of Seasonal and Pandemic Influenza Am J Public Health, October 1, 2009; 99(S2): S216 - S224. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. E. Basta, D. L. Chao, M. E. Halloran, L. Matrajt, and I. M. Longini Jr Strategies for Pandemic and Seasonal Influenza Vaccination of Schoolchildren in the United States Am. J. Epidemiol., September 15, 2009; 170(6): 679 - 686. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Fraser, C. A. Donnelly, S. Cauchemez, W. P. Hanage, M. D. van Kerkhove, T. D. Hollingsworth, J. Griffin, R. F. Baggaley, H. E. Jenkins, E. J. Lyons, et al. Response--Influenza Science, August 28, 2009; 325(5944): 1072 - 1073. [Full Text] [PDF]
|
|
|
|
 |
|
 H. Nishiura, G. Chowell, H. Heesterbeek, and J. Wallinga The ideal reporting interval for an epidemic to objectively interpret the epidemiological time course J R Soc Interface, July 1, 2009; (2009) rsif.2009.0153v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Novel Swine-Origin Influenza A (H1N1) Virus Invest Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans N. Engl. J. Med., June 18, 2009; 360(25): 2605 - 2615. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Wood, J. McCaw, N. Becker, T. Nolan, and C. R. MacIntyre Optimal Dosing and Dynamic Distribution of Vaccines in an Influenza Pandemic Am. J. Epidemiol., June 15, 2009; 169(12): 1517 - 1524. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Lowen, J. Steel, S. Mubareka, E. Carnero, A. Garcia-Sastre, and P. Palese Blocking Interhost Transmission of Influenza Virus by Vaccination in the Guinea Pig Model J. Virol., April 1, 2009; 83(7): 2803 - 2818. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. E. Basta, M. E. Halloran, L. Matrajt, and I. M. Longini Jr. Estimating Influenza Vaccine Efficacy From Challenge and Community-based Study Data Am. J. Epidemiol., December 15, 2008; 168(12): 1343 - 1352. [Abstract] [Full Text] [PDF]
|
|